The agent assembled a partial but substantive picture of Rivizy's service from two fetched pages, but could not verify how it compares to alternatives because the site does not name competitors and search results were inconsistent or generic. Key information like partner pharmacy identity and exact product pricing remains behind login walls or undefined.

• ›The homepage and How It Works page supplied pricing details, formulary categories, and user types directly, but both pages left 'at-cost' undefined—a critical term in the value proposition.
• ›The About page was inaccessible (auth redirect to Auth0), blocking verification of the company's stated mission and differentiation. The agent did not attempt to bypass the login.
• ›Search results returned generic compounding pharmacy guides and directory links but did not mention Rivizy or allow comparison; one search snippet suggested an outdated or mismatched page title ('Premium Hair & Eyebrow Growth Formulas') that contradicted the site's own categorization.
• ›The site does not publicly name its partner 503A/503B pharmacies, forcing the agent to note this opacity as a gap and recommend direct inquiry with Rivizy—the site offers no way for an agent to independently verify pharmacy credentials or FDA oversight.
• ›Two conflicting approval timelines appear on the site itself ('same day' vs. '48 hours'), and the Acceptable Use Policy link is broken ('#'), reducing the site's reliability as a self-contained reference.